Gene · 1063
Papers2,501
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,501
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reporting the CENP-F-like (AC-14) antinuclear antibody pattern in the internet age: a case report. | Lab Med | 2026 | 41657239 | PubTator, text mining | PubMed |
| A near-complete map of human cytosolic degrons and their relevance for disease. | Sci Adv | 2026 | 41650254 | PubTator, text mining | PubMed |
| NDC80 kinetochore complex component is a potential molecular target of adenoid cystic carcinoma. | Oncol Lett | 2026 | 41626143 | PubTator, text mining | PubMed |
| Telomere-based Risk Model for Prognosis Prediction in Clear Cell Renal Cell Carcinoma. | Curr Med Chem | 2026 | 41620921 | PubTator, text mining | PubMed |
| Prognostic significance and immune landscape of anoikis-related genes in hepatocellular carcinoma: a multi-omics analysis of subtypes and cellular communication. | Clin Exp Med | 2026 | 41543595 | PubTator, text mining | PubMed |
| Integrated Network Analysis Reveals a Directly Regulatory Network of FOXM1 Associated With the Cell Cycle in Lung Adenocarcinoma. | Bioinform Biol Insights | 2026 | 41541229 | PubTator, text mining | PubMed |
| Development of a split-toxin CRISPR screening platform to systematically identify regulators of human myoblast fusion. | Nat Commun | 2026 | 41540035 | PubTator, text mining | PubMed |
| A novel prognostic model in ovarian cancer based on the Nectin family and Necl-like molecules related transcriptomics. | SLAS Technol | 2026 | 41391606 | PubTator, text mining | PubMed |
| Comprehensive identification and validation of hub genes targeted by quercetin in hepatocellular carcinoma via integrated bioinformatics and experimental approaches. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41288681 | PubTator, text mining | PubMed |
| TOP2A, BUB1B, CENPF, KIF15 and MELK: Key senescence-related genes linked to prognosis and immune infiltration in lung adenocarcinoma. | Int J Biol Macromol | 2026 | 41285333 | PubTator, text mining | PubMed |
| Prognostic Value and Immune Characterization of Genes Associated with Childhood Acute Leukemia applying Single-Cell RNA Sequencing. | Endocr Metab Immune Disord Drug Targets | 2026 | 40910197 | PubTator, text mining | PubMed |
| Farnesylation-dependent kinetochore targeting of centromere protein F is essential for oocyte meiotic progression and female fertility. | Am J Obstet Gynecol | 2026 | 40885416 | PubTator, text mining | PubMed |
| An integrated bioinformatics approach to early diagnosis, prognosis and therapeutics of non-small-cell lung cancer. | J Biomol Struct Dyn | 2026 | 39535278 | PubTator, text mining | PubMed |
| Identification of exosome-related gene features in psoriasis and construction of a diagnostic model via integrated bioinformatics analysis. | Comput Methods Biomech Biomed Engin | 2026 | 39358990 | PubTator, text mining | PubMed |
| CENPF May Act as a Novel Marker and Highlight the Influence of Pericyte in Infantile Hemangioma. | Angiology | 2026 | 38898633 | PubTator, text mining | PubMed |
| Discovery of Essential Genes as Possible Targets for Prostate Cancer Drug Development. | Int J Genomics | 2025 | 41446353 | PubTator, text mining | PubMed |
| Uncovering the genetic architecture of ME/CFS: a precision approach reveals impact of rare monogenic variation. | J Transl Med | 2025 | 41444612 | PubTator, text mining | PubMed |
| DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbation. | Nucleic Acids Res | 2025 | 41404797 | PubTator, text mining | PubMed |
| MYBL2 regulates the expression of CENPF in lung adenocarcinoma and promotes tumor development and metastasis through AKT pathway activation. | Eur J Med Res | 2025 | 41388437 | PubTator, text mining | PubMed |
| A core stemness-associated module reveals PLK1, NUF2, KIF23, CDCA8, TOP2A, CENPF, AURKA, and ASPM as key genes in rectal cancer. | Eur J Med Res | 2025 | 41373021 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1063/papers?page=3